Woman using the Somryst™ app on her phone

Get started on Somryst
by connecting with a healthcare provider

Find a Provider

Talk to your healthcare provider about a Somryst prescription or get started with telemedicine by following these 3 steps:

1
Complete the sleep questionnaire

Before you begin, you’ll create an account with a third-party telemedicine provider and explain a little about yourself. Then you’ll complete a quick questionnaire about your sleep habits and medical history.

  • Once you’ve completed the questionnaire, you can set up an online consultation with a board-certified healthcare provider
  • The answers you provide in the questionnaire help inform the healthcare provider during your consultation whether you’re a good candidate for Somryst®
Woman speaking to a healthcare provider via telemedicine

2
Consult with a licensed healthcare provider

Schedule an appointment and submit the $25 consultation fee. You and the healthcare provider of your choice will discuss whether Somryst is right for you. If it is, you’ll receive a prescription.

  • Select the board-certified healthcare provider of your choice from an extensive list provided by the third-party telemedicine partner
  • Choose how you want to meet with your healthcare provider. Depending on your state of residence, you can sometimes choose between a video chat, phone call, or even just email.
  • This secure consultation can take place from the comfort of wherever you are and whenever is best for you
Woman speaking to a healthcare provider via telemedicine

3
Download Somryst

You’ll receive a text from Pear’s Patient Service Center and a third-party pharmacy. They will walk you through a simple setup process to get started with telemedicine, which includes completing your Somryst purchase and downloading the app.

  • To receive treatment, verify your identity with a digital signature
  • Set up payment (don’t forget, if eligible, to use your Somryst Savings Card)
  • Download the app, and get started on your journey to better sleep
WWoman using the Somryst™ app on her phone

How you can pay for Somryst

Available with a
Savings Card*
For your eligible patients
Flexible payment options
1-time payment
or
3 monthly payments
Use of
FSA/HSA
account funds
*Terms and conditions apply.
Moon icon
Pear’s Patient Service Center will help determine insurance coverage during onboarding.

Frequently asked questions

Do I need to see a healthcare provider face-to-face in a telemedicine visit?

It depends on where you live. In certain states, you can sometimes choose between a video chat, phone call, or even email.

Is this all legal and above board?

Of course. Telemedicine is a rapidly growing way of accessing healthcare, particularly in the midst of a global pandemic. The third-party telemedicine provider, UpScript, only uses experienced, licensed healthcare providers to diagnose and treat chronic insomnia.

How quickly will a healthcare provider review my information?

It really depends on when you start the process. Sometimes you can arrange a same-day consultation.

Why do I need to fill out a form before I talk with a healthcare provider?

To help determine if you have chronic insomnia, healthcare providers will need to learn more about your everyday experience with sleep.

Do I have to pay for my appointment?

Yes. Each appointment costs $25.

When will I be charged for Somryst?

After you receive your prescription, you’ll receive some more information from our team at the Patient Service Center via text. During that exchange, we’ll give you payment options.

Are there payment options?

There sure are! We currently accept a 1-time payment as well as a payment plan of 3 months. You can also pay for Somryst using funds from your FSA/HSA.

Can my healthcare provider prescribe Somryst?

But of course! If any questions come up along the way, you can always direct your healthcare provider to call Pear’s Patient Service Center at 1-833-697-3738. However, if you want to skip the trip, telemedicine is an option as well. From virtual consultation to downloading the app, starting your journey toward a better night’s sleep can be as easy as sitting at home and using our Find A Provider tool to connect with a healthcare provider.

Ready to take on your chronic insomnia?

Indications for Use

Somryst® is a prescription-only digital therapeutic intended to provide a neurobehavioral intervention (CBT-I) to patients 22 years of age and older with chronic insomnia. Somryst treats patients with chronic insomnia by improving a patient’s insomnia symptoms.

Who Should Use Somryst?

You should use Somryst if you:

  • Are 22 or older with chronic insomnia
  • Are able to read and understand English
  • Have regular access to a mobile device (such as smartphone or tablet)
  • Are familiar with how to use mobile apps (applications)
  • Are able to upload data periodically. (In other words, you have internet/wireless connection access.)
  • Are under the supervision of a Health Care Provider
Who Should Not Use Somryst® (Contraindications)

Somryst uses sleep restriction and consolidation, limiting the time you spend in bed to match the amount of time you sleep. Sleep restriction and consolidation may worsen preexisting medical conditions. Because of this, it is not appropriate for everyone.

If you have any of the following conditions or disorders, you should not use Somryst:

  • Any disorder worsened by sleep restriction (e.g. bipolar disorder, schizophrenia, other psychotic spectrum disorders)
  • Untreated obstructive sleep apnea
  • Parasomnias
  • Epilepsy
  • If you are at high risk of falls
  • If you are pregnant
  • If you have any other unstable or degenerative illness judged to be worsened by sleep restriction delivered as part of Cognitive Behavioral Therapy for Insomnia

If you are unsure whether you have any of the conditions or disorders listed, speak with your Health Care Provider.

Safety Warnings

Somryst® is not for everyone. You and your Health Care Provider should discuss whether Somryst is right for you.

  • Somryst is not for emergency use. Please dial 911 or go to the nearest emergency room in the event of a medical emergency.
  • Do not use Somryst to communicate severe or urgent information to your Health Care Provider.
  • Somryst is not meant to be used as treatment except under supervision of your Health Care Provider.
  • Somryst is not meant to be a substitution for any treatment medication.
  • Somryst contains sensitive medical information about you. It is important that you protect your information by password-protecting your smartphone or tablet and ensuring no one else has access to your device.
  • Sleep Restriction (and Consolidation) within Somryst can cause sleepiness, especially in the early stages of using the PDT. Somryst should not be used if you need to be alert or cautious to avoid serious accidents in your job or daily life. Examples include:
    — Long-haul truck drivers
    — Long-distance bus drivers
    — Air traffic controllers
    — Operators of heavy machinery
    — Some assembly line jobs
  • The usage data collected in therapy lessons by Somryst are not intended to be used as a standalone assessment of treatment progress.

Note: In the early stages of treatment, increased daytime sleepiness may be expected, but is usually temporary. However, if these experiences do not go away over a few weeks, please consult your health care provider as you may have a sleep disorder or medical condition other than insomnia. Also, at any point in the treatment, if you have trouble staying awake while performing potentially dangerous tasks (like driving) avoid these tasks or stop following the sleep restriction component of the therapy.

For best results with Somryst, read and follow the instructions provided in each core, and stay with the therapy until the end. When reporting your sleep results, giving honest and accurate answers is important.

Care Regimen and Self-care

Following your Health Care Provider’s instructions for care is always important. If you need help managing your condition, speak with your Health Care Provider.

Disclaimer: No user or party is compensated for prescribing Somryst or for being included in this list. Pear Therapeutics is not liable or responsible for any diagnosis, treatment decision, or other decisions made up by the providers and/or facilities listed.

This tool is updated on an ongoing basis to reflect our most up-to-date list of providers and facilities currently prescribing Somryst.

If you are a provider or facility that is interested in prescribing Somryst, or to learn more, please contact 1-833-697-3738.

References: 1. Insomnia. Mayo Clinic. Accessed May 19, 2022. https://www.mayoclinic.org/diseases-conditions/insomnia/symptoms-causes/syc-20355167 2. Anderson KN. Insomnia and cognitive behavioural therapy-how to assess your patient and why it should be a standard part of care. J Thorac Dis. 2018;10(Suppl 1):S94-S102. doi:10.21037/jtd.2018.01.35. 3. Feuerstein S, Hodges SE, Keenaghan B, Bessette A, Forselius E, Morgan PT. Computerized Cognitive Behavioral Therapy for Insomnia in a Community Health Setting. J Clin Sleep Med. 2017;13(2):267-274. doi:10.5664/jcsm.6460. 4. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;165(2):125-33. doi: 10.7326/M15-2175. 5. Substance Abuse and Mental Health Services Administration. (2016). Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. CBHSQ Methodology Report. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD. Accessed May 19, 2022. https://www.ncbi.nlm.nih.gov/books/NBK519697/ 6. QuickFacts United States. US Census Bureau. Accessed May 19, 2022. https://www.census.gov/quickfacts/fact/table/US# 7. Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, Sateia MJ, Troxel WM, Zhou ES, Kazmi U, Heald JL, Martin JL. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255-262. doi: 10.5664/jcsm.8986. PMID: 33164742; PMCID: PMC7853203.